As COVID-19 vaccinations climb in developed markets, the picture in emerging markets remains idiosyncratic where the vaccine rollout remains a critical question.
The global environment is changing in ways that favor further rotation toward emerging market value, such as the transition to clean energy.
Understanding innovation and disruption is critical to identifying stocks that could be long-term compounders.
Over the past year, we have seen strong momentum on global regulatory efforts to combat climate change.
Executive order could encourage regulators to address concerns about consolidation and competition in a range of industries.
Central banks are expanding beyond their traditional objectives to incorporate social and environmental issues, such as climate change.
Rising inflation is more difficult for U.S. growth companies, near term, but our longer-term outlook remains positive.
Find out why we believe the “value” recovery can be maintained.
Contact your T. Rowe Price representative to find out how we can take your plan to the next level.